WA Centre for Health and Ageing,
Led by WACHA’s Professor Christopher Etherton-Beer, the OptiMed deprescribing study was a double-blind RCT in RACFs where two…
Led by WACHA’s Professor Christopher Etherton-Beer, the OptiMed deprescribing study was a double-blind RCT in RACFs where two…
The OptiMed deprescribing study was a double-blind RCT in RACFs where two pharmacists chose the medicines to target for…
The first two papers from the double blind placebo controlled study of deprescribing called Opti-Med are now published. This…
The first two papers from the double blind placebo controlled study of deprescribing called Opti-Med are now published. This…